Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

Similar articles for PubMed (Select 24560170)

1.

Recommendations for the management of cardiovascular risk in patients with rheumatoid arthritis: scientific evidence and expert opinion.

Martín-Martínez MA, González-Juanatey C, Castañeda S, Llorca J, Ferraz-Amaro I, Fernández-Gutiérrez B, Díaz-González F, González-Gay MA.

Semin Arthritis Rheum. 2014 Aug;44(1):1-8. doi: 10.1016/j.semarthrit.2014.01.002. Epub 2014 Jan 24. Review.

PMID:
24560170
2.

EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis.

Peters MJ, Symmons DP, McCarey D, Dijkmans BA, Nicola P, Kvien TK, McInnes IB, Haentzschel H, Gonzalez-Gay MA, Provan S, Semb A, Sidiropoulos P, Kitas G, Smulders YM, Soubrier M, Szekanecz Z, Sattar N, Nurmohamed MT.

Ann Rheum Dis. 2010 Feb;69(2):325-31. doi: 10.1136/ard.2009.113696. Epub 2009 Sep 22.

PMID:
19773290
3.

Cardiovascular risk and rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion.

Pham T, Gossec L, Constantin A, Pavy S, Bruckert E, Cantagrel A, Combe B, Flipo RM, Goupille P, Le Loët X, Mariette X, Puéchal X, Schaeverbeke T, Sibilia J, Tebib J, Wendling D, Dougados M.

Joint Bone Spine. 2006 Jul;73(4):379-87. Epub 2006 Mar 29.

PMID:
16690341
4.

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update.

Smolen JS, Landewé R, Breedveld FC, Buch M, Burmester G, Dougados M, Emery P, Gaujoux-Viala C, Gossec L, Nam J, Ramiro S, Winthrop K, de Wit M, Aletaha D, Betteridge N, Bijlsma JW, Boers M, Buttgereit F, Combe B, Cutolo M, Damjanov N, Hazes JM, Kouloumas M, Kvien TK, Mariette X, Pavelka K, van Riel PL, Rubbert-Roth A, Scholte-Voshaar M, Scott DL, Sokka-Isler T, Wong JB, van der Heijde D.

Ann Rheum Dis. 2014 Mar;73(3):492-509. doi: 10.1136/annrheumdis-2013-204573. Epub 2013 Oct 25.

5.

Canadian Rheumatology Association recommendations for pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs.

Bykerk VP, Akhavan P, Hazlewood GS, Schieir O, Dooley A, Haraoui B, Khraishi M, Leclercq SA, Légaré J, Mosher DP, Pencharz J, Pope JE, Thomson J, Thorne C, Zummer M, Bombardier C; Canadian Rheumatology Association.

J Rheumatol. 2012 Aug;39(8):1559-82. doi: 10.3899/jrheum.110207. Epub 2011 Sep 15.

6.

Canadian Rheumatology Association recommendations for the pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs: part II safety.

Bombardier C, Hazlewood GS, Akhavan P, Schieir O, Dooley A, Haraoui B, Khraishi M, Leclercq SA, Légaré J, Mosher DP, Pencharz J, Pope JE, Thomson J, Thorne C, Zummer M, Gardam MA, Askling J, Bykerk V; Canadian Rheumatology Association.

J Rheumatol. 2012 Aug;39(8):1583-602. doi: 10.3899/jrheum.120165. Epub 2012 Jun 15.

7.

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs.

Smolen JS, Landewé R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C, Gorter S, Knevel R, Nam J, Schoels M, Aletaha D, Buch M, Gossec L, Huizinga T, Bijlsma JW, Burmester G, Combe B, Cutolo M, Gabay C, Gomez-Reino J, Kouloumas M, Kvien TK, Martin-Mola E, McInnes I, Pavelka K, van Riel P, Scholte M, Scott DL, Sokka T, Valesini G, van Vollenhoven R, Winthrop KL, Wong J, Zink A, van der Heijde D.

Ann Rheum Dis. 2010 Jun;69(6):964-75. doi: 10.1136/ard.2009.126532. Epub 2010 May 5. Review. Erratum in: Ann Rheum Dis. 2011 Aug;70(8):1519.

8.

Therapy Insight: managing cardiovascular risk in patients with rheumatoid arthritis.

Giles JT, Post W, Blumenthal RS, Bathon JM.

Nat Clin Pract Rheumatol. 2006 Jun;2(6):320-9. Review.

PMID:
16932711
9.

German guidelines for the sequential medical treatment of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs.

Albrecht K, Krüger K, Wollenhaupt J, Alten R, Backhaus M, Baerwald C, Bolten W, Braun J, Burkhardt H, Burmester GR, Gaubitz M, Gause A, Gromnica-Ihle E, Kellner H, Kuipers J, Krause A, Lorenz HM, Manger B, Nüßlein H, Pott HG, Rubbert-Roth A, Schneider M, Specker C, Schulze-Koops H, Tony HP, Wassenberg S, Müller-Ladner U; German Society of Rheumatology.

Rheumatol Int. 2014 Jan;34(1):1-9. doi: 10.1007/s00296-013-2848-3. Epub 2013 Aug 14. Review.

PMID:
23942828
10.

Cardiovascular risk in rheumatoid arthritis: how to lower the risk?

van Breukelen-van der Stoep DF, Klop B, van Zeben D, Hazes JM, Castro Cabezas M.

Atherosclerosis. 2013 Nov;231(1):163-72. doi: 10.1016/j.atherosclerosis.2013.09.006. Epub 2013 Sep 20. Review.

PMID:
24125429
11.

Cardiovascular risk in rheumatoid arthritis.

Nurmohamed MT.

Autoimmun Rev. 2009 Jul;8(8):663-7. doi: 10.1016/j.autrev.2009.02.015. Epub 2009 Feb 12. Review.

PMID:
19393192
12.

Developing multidisciplinary guidelines for the management of early rheumatoid arthritis.

Hennell S, Luqmani R.

Musculoskeletal Care. 2008 Jun;6(2):97-107.

PMID:
18044796
13.

EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

Combe B, Landewe R, Lukas C, Bolosiu HD, Breedveld F, Dougados M, Emery P, Ferraccioli G, Hazes JM, Klareskog L, Machold K, Martin-Mola E, Nielsen H, Silman A, Smolen J, Yazici H.

Ann Rheum Dis. 2007 Jan;66(1):34-45. Epub 2006 Jan 5.

14.

Reducing the cardiovascular disease burden in rheumatoid arthritis.

Van Doornum S, Jennings GL, Wicks IP.

Med J Aust. 2006 Mar 20;184(6):287-90. Review.

PMID:
16548834
15.

Cardiovascular disease in rheumatoid arthritis: a step forward.

Myasoedova E, Gabriel SE.

Curr Opin Rheumatol. 2010 May;22(3):342-7. doi: 10.1097/BOR.0b013e3283379b91. Review.

PMID:
20164773
16.
17.

Cardiovascular risk and the use of biologic agents in rheumatoid arthritis.

Lim DT, Cannella AC, Michaud KD, Mikuls TR.

Curr Rheumatol Rep. 2014 Nov;16(11):459. doi: 10.1007/s11926-014-0459-y. Review.

PMID:
25315196
18.

Increased cardiovascular risk in patients with rheumatoid arthritis: an overview.

Puttevils D, De Vusser P, Geusens P, Dens J.

Acta Cardiol. 2014 Apr;69(2):111-8. Review.

PMID:
24783461
19.

Structural evaluation in the management of patients with rheumatoid arthritis: development of recommendations for clinical practice based on published evidence and expert opinion.

Gossec L, Fautrel B, Pham T, Combe B, Flipo RM, Goupille P, Le Loet X, Mariette X, Puéchal X, Wendling D, Schaeverbeke T, Sibilia J, Sany J, Dougados M.

Joint Bone Spine. 2005 May;72(3):229-34.

PMID:
15850994
20.

Cardiovascular risk in rheumatoid arthritis.

Soubrier M, Barber Chamoux N, Tatar Z, Couderc M, Dubost JJ, Mathieu S.

Joint Bone Spine. 2014 Jul;81(4):298-302. doi: 10.1016/j.jbspin.2014.01.009. Epub 2014 May 28. Review.

PMID:
24880190
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk